RECCE PHARMACEUTICALS LTD - News & Media

Market Cap $118.1M Add to my watchlist

Recce Pharmaceuticals Ltd is an Australia-based company engaged in the development and... Recce Pharmaceuticals Ltd is an Australia-based company engaged in the development and commercialization of a new class of synthetic anti-infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral pathogens. The Company's anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company's anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are water soluble at all pH levels in their liquid form.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No News & Media currently available.

(20min delay)
Last 43.0¢		Change -0.010(2.27%)		Mkt cap ! $118.1M

Open	High	Low	Value	Volume
44.0¢	44.5¢	43.0¢	$130.8K	297.2K

Buyers (Bids)

No.	Vol.	Price($)
4	31774	43.0¢

Sellers (Offers)

Price($)	Vol.	No.
44.0¢	13243	1

View Market Depth

No.	Vol.	Price($)
3	35701	0.510
1	2928	0.505
2	29692	0.500
1	30000	0.495
1	50000	0.490

Price($)	Vol.	No.
0.520	6981	1
0.525	27349	2
0.530	10000	1
0.545	1834	1
0.550	54490	2

Last trade - 16.10pm 02/12/2024 (20 minute delay)


Last 44.0¢		Change -0.010 ( 1.12 %)
Open	High	Low	Volume
44.0¢	44.5¢	44.0¢	87918
Last updated 14.19pm 02/12/2024 ?

RCE (ASX) Chart